Key Statistics for CPHD
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CPHD
- Net Income (M/USD)
Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.
More Company Profile & Key Executives for CPHD
|John L BishopChairman/CEO||Andrew D MillerExec VP/CFO|
|Humberto ReyesExec VP/COO||David H PersingExec VP/Chief Medical Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries